Remote West Coast VP Biologics Development

Syner-G; United States; Remote; USD 220,000 - 350,000; Full time

Benefits offered by this job

Competitive base salary

Annual incentive plan

Fully remote work options

Flexible paid time off

Job summary

Syner-G BioPharma Group is seeking a Vice President of Biologics Development to anchor our West Coast presence and drive client development and market credibility. The role is remote with substantial travel to client sites, industry events, and business development activities.

You will lead biologics CMC engagements, oversee process development, analytical characterization, and regulatory strategy, and represent the firm at industry forums.

Qualifications

• Advanced degree in biochemistry, chemical engineering, pharmaceutical sciences, or related field.
• 20+ years of biologics CMC experience with major sponsor backgrounds.
• Deep expertise in at least two areas: upstream/downstream, analytical development, drug product formulation, or CMC regulatory affairs.
• Experience in business development or client relationships at CRO/CDMO/consulting firm.

Responsibilities

• Lead and execute biologics CMC consulting engagements across the program lifecycle.
• Provide expert guidance on upstream/downstream process development, analytical development, and regulatory strategy.
• Author strategic input on CMC regulatory submissions including INDs and BLAs.
• Collaborate with other groups to deliver integrated solutions and maintain delivery accountability.

Skills

Biologics CMC

Process development

Regulatory strategy

IND/BLAs

Client relations

Team leadership

Project management

Education

PhD/MS in relevant field

Job description

Syner-G BioPharma Group is seeking a Vice President of Biologics Development to anchor our West Coast presence and drive client development and market credibility. The role is remote with substantial travel to client sites, industry events, and business development activities.

You will lead biologics CMC engagements, oversee process development, analytical characterization, and regulatory strategy, and represent the firm at industry forums.